## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims made in the abstract
- **Shared manuscript claim summary** The authors present DisoRDPbind, a web server tool for predicting intrinsically disordered regions (IDRs) that bind RNA, and describe its model, performance, runtime, and utility, including a case study on the HCV core protein.
- **Visible evidence base** Abstract text only; no figures, tables, or supplementary materials provided
- **Missing materials affecting confidence** Full manuscript, including methods, performance data, figures, tables, and the case study details; no access to the web server or its documentation

## Reviewer
- **Overall assessment** The abstract describes a potentially useful tool for predicting RNA-binding IDRs, a niche area with few existing predictors. However, the abstract lacks sufficient detail to evaluate the novelty, performance, or technical soundness of DisoRDPbind. The claims are broad and unsupported by the provided material, and the case study is mentioned but not substantiated. The abstract reads more as a protocol or user guide than a research article, which may limit its impact for a general audience.
- **Who would be interested in the results, and why** Researchers studying intrinsically disordered proteins, RNA biology, and RNA chaperones may find the tool useful for identifying candidate RNA-binding IDRs. The small computational footprint and web server accessibility could appeal to those performing proteome-scale analyses. However, the abstract does not demonstrate how the tool advances beyond existing methods, limiting its appeal to a broader readership.
- **Major strengths** 
  - Addresses a specific and under-served prediction problem (RNA-binding IDRs).
  - Tool is available as a web server, facilitating use by the community.
  - Highlights computational efficiency, which is practical for large-scale studies.
- **Major Concerns**
  - **Concern ID** R1-M1
    **Severity** Major
    **Blocking** Yes
    **Axis** Scientific importance / Technical soundness
    **Claim pointer** "We describe the predictive model employed by DisoRDPbind and discuss its predictive performance and runtime, which were recently measured in the second CAID experiment."
    **Evidence pointer** Abstract only; location not provided
    **Concern** The abstract claims that the model's performance and runtime were measured in the CAID experiment, but no performance metrics (e.g., accuracy, precision, recall, AUC) or runtime comparisons are provided. Without these data, the reader cannot assess whether the tool is reliable or competitive.
    **Why it matters** For a prediction tool, quantitative performance evaluation is essential to establish its utility and trustworthiness. The lack of such data undermines the core claim of the manuscript.
    **Resolution test** Provide a summary of key performance metrics (e.g., AUC, precision, recall) from the CAID experiment, and ideally compare them to existing methods for RNA-binding IDR prediction.
  - **Concern ID** R1-M2
    **Severity** Major
    **Blocking** Yes
    **Axis** Originality / Scientific importance
    **Claim pointer** "We focus on one of the first tools designed to predict RNA-binding IDRs: DisoRDPbind."
    **Evidence pointer** Abstract only; location not provided
    **Concern** The claim that DisoRDPbind is "one of the first tools" for this task is vague and unsupported. The abstract does not cite or compare with any existing predictors, making it impossible to evaluate the novelty or relative position of this tool.
    **Why it matters** Without a clear statement of what distinguishes DisoRDPbind from prior work, the manuscript's contribution to the field is unclear. This is critical for establishing scientific importance.
    **Resolution test** Provide a brief comparison with existing RNA-binding IDR predictors, highlighting unique features or advantages of DisoRDPbind.
  - **Concern ID** R1-M3
    **Severity** Major
    **Blocking** Yes
    **Axis** Interdisciplinary readership / Readability for nonspecialists
    **Claim pointer** "We present a case study of an RNA chaperone, HCV core protein, to illustrate the method's utility in studying RNA chaperones."
    **Evidence pointer** Abstract only; location not provided
    **Concern** The case study is mentioned but not described. The abstract does not explain what predictions were made, how they were validated, or what insights were gained. This makes the claim of utility unsubstantiated.
    **Why it matters** Case studies are a key way to demonstrate practical relevance. Without details, the reader cannot assess whether the tool is genuinely useful for studying RNA chaperones.
    **Resolution test** Include a brief summary of the case study results, such as predicted RNA-binding regions in the HCV core protein and any biological interpretation.
- **Minor Comments**
  - **Concern ID** R1-m1
    **Severity** Minor
    **Axis** Readability for nonspecialists
    **Affected element** Abstract text
    **Evidence pointer** Abstract only; location not provided
    **Issue** The abstract uses the acronym "IDR" without defining it in the first sentence, which may confuse readers unfamiliar with the field.
    **Required correction** Define "intrinsically disordered regions (IDRs)" at first use, or ensure the full term is used before the acronym.
  - **Concern ID** R1-m2
    **Severity** Minor
    **Axis** Readability for nonspecialists
    **Affected element** Abstract text
    **Evidence pointer** Abstract only; location not provided
    **Issue** The abstract mentions "CAID (Critical Assessment of protein Intrinsic Disorder) experiment" but does not explain what this benchmark entails or why it is relevant.
    **Required correction** Briefly describe the CAID experiment (e.g., "a community-wide blind test for IDR prediction") to help readers understand the context of the performance evaluation.
- **Technical failings that need to be addressed before the case is established** R1-M1 (lack of performance data), R1-M2 (lack of novelty context), R1-M3 (lack of case study details)
- **Assessment against Nature-style criteria** 
  - **Originality**: Not established. The abstract does not demonstrate how DisoRDPbind differs from or improves upon existing tools.
  - **Scientific importance**: Weak. The problem is relevant, but the abstract provides no evidence that the tool is accurate, novel, or impactful.
  - **Interdisciplinary readership**: Limited. The abstract is written as a protocol, with no broader context or implications for fields beyond computational biology.
  - **Technical soundness**: Not assessable. No performance data, model details, or validation are provided.
  - **Readability for nonspecialists**: Moderate. The abstract is clear but uses jargon without explanation, and the case study is too vague to be informative.
- **Recommendation posture** Currently not established from the provided evidence. The abstract lacks the quantitative and comparative data needed to support the claims of utility and novelty. A full manuscript with performance metrics, comparisons, and a detailed case study would be required for a supportive assessment.

## Risk / unsupported claims
- "One of the first tools designed to predict RNA-binding IDRs" – unsupported; no comparison with existing tools.
- "Predictive performance and runtime were recently measured in the second CAID experiment" – unsupported; no performance data provided.
- "Small computational footprint allows for large/proteome-scale predictions" – unsupported; no runtime or scalability data.
- "Case study of an RNA chaperone, HCV core protein, to illustrate the method's utility" – unsupported; no results or interpretation given.